Latest news
Medtronic (MDT) Wins Expanded CE Mark For Affera System In Ventricular Arrhythmias - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 02:09:00 GMTMedtronic’s all-in-one mapping and ablation system gains expanded CE mark approval - Cardiovascular BusinessCardiovascular Business · Fri, 07 Aug 2026 20:30:01 GMTMedtronic gets CE mark for ablation to treat ventricular tachycardia - MedTech DiveMedTech Dive · Fri, 07 Aug 2026 15:33:45 GMTMedtronic's Sphere-9 catheter gets CE Mark for ventricular arrhythmia treatment, advancing patient care. - PluangPluang · Thu, 06 Aug 2026 20:53:23 GMTMedtronic announces expanded CE-mark indication of Affera system for ventricular arrhythmia treatment - Cardiac Rhythm NewsCardiac Rhythm News · Thu, 06 Aug 2026 16:14:16 GMTExpanded CE Mark Indication Granted to Medtronic’s Affera Mapping and Ablation System - Medical Product OutsourcingMedical Product Outsourcing · Thu, 06 Aug 2026 14:39:37 GMTMedtronic wins expanded indication in Europe for Affera to treat VT - massdevice.commassdevice.com · Thu, 06 Aug 2026 12:37:39 GMTMedtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias - PR NewswirePR Newswire · Thu, 06 Aug 2026 11:00:00 GMT